Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
about
Lipid-lowering efficacy of atorvastatinLipid lowering efficacy of atorvastatinMeta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol.Food Ingredients That Inhibit Cholesterol Absorption.Policosanols as nutraceuticals: fact or fiction.Policosanol attenuates statin-induced increases in serum proprotein convertase subtilisin/kexin type 9 when combined with atorvastatin.Trace quantification of 1-triacontanol in beagle plasma by GC-MS/MS and its application to a pharmacokinetic study.Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.Nutraceutical and functional scenario of wheat straw.Functional foods and dietary supplements for the management of dyslipidaemia.Stress Degradation Behavior of Atorvastatin Calcium and Development of a Suitable Stability-Indicating LC Method for the Determination of Atorvastatin, its Related Impurities, and its Degradation ProductsSafety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results.Investigation on pharmacokinetics, tissue distribution and excretion of 1-triacontanol in rats by gas chromatography-tandem mass spectrometry (GC-MS/MS)
P2860
Q24187301-E0CE109F-CAB8-4771-B043-9C3ABD0E7637Q24202363-3D9143A7-2FD6-4021-AAAE-E8213AE13366Q30848020-F47C5DD9-C69C-4791-972C-3D738E868C6AQ33888461-42B54D99-0FDD-4A43-94E2-F066BF2BD4C8Q34105246-EFA6C3DA-EA7D-498F-A0E8-51410D992CB4Q34588435-95CFDDD6-2AE1-4B3B-B074-4FCE6B2A42E6Q35352306-005587EE-D6F3-41FE-BA0E-BC1088E55DB7Q36844596-8268FC0D-CA32-4F54-9983-556BA0CE985EQ37663465-DAA23C6F-0129-42C7-9F74-CE987CA11676Q38025713-75F4B4BF-F456-4B88-8BD6-B0BD07388960Q38065236-DEDAC02C-0529-444C-A933-9D441DE330A0Q39108473-EAB297CA-90D9-411A-8C43-274494F377C6Q39625048-1FD4ED1D-55CD-48E8-B5E4-3BD308E3594CQ40689554-4C00C938-7B95-4DE3-80C7-9E7C78FE8D7EQ57148204-33031CC7-F7BA-44B2-ABAA-2FB34ECC6388
P2860
Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@ast
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@en
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@nl
type
label
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@ast
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@en
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@nl
prefLabel
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@ast
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@en
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@nl
P2093
P1433
P1476
Comparison of the efficacy and ...... type II hypercholesterolaemia.
@en
P2093
Estrella Alvarez
Gladys Castaño
José Illnait
Lilia Fernández
Magnolia Lezcay
Meylin Mesa
P304
P356
10.2165/00002512-200320020-00006
P577
2003-01-01T00:00:00Z
P6179
1034006378